Time required to achieve optimum viral load suppression with Ravidasvir/sofosbuvir in chronic hepatitis C patients with or without compensated cirrhosis. [PDF]
Muhamad NA+7 more
europepmc +1 more source
NS3 of hepatitis C virus drives hepatocellular carcinoma progression through a novel RNA-interference pathway. [PDF]
Liang Y, Luo J, Hu L, Zhang J.
europepmc +1 more source
Epidemiological characteristics and treatment challenges of chronic hepatitis C in the kashi region of xinjiang china: A retrospective investigation from 2018 to 2022. [PDF]
Li M+6 more
europepmc +1 more source
Integrative analysis of serum proteomics and transcriptomics in hepatitis C. [PDF]
Wang J+7 more
europepmc +1 more source
The association between drug injection duration and hepatitis C prevalence among people who inject drugs in Iran. [PDF]
Haji-Maghsoudi S+5 more
europepmc +1 more source
Incidence and determinants of extrapulmonary tuberculosis in Egypt: a retrospective cohort study. [PDF]
Amin W+7 more
europepmc +1 more source
Pilot Findings From the First Legalized Mobile Retail Pharmacy Clinic in the United States for Infectious Disease Treatment and Prevention Tailored to Reach People Who Use Drugs. [PDF]
Tarfa A+6 more
europepmc +1 more source
Providers' Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative Study. [PDF]
Finbråten AK+6 more
europepmc +1 more source